Neuropathy in neurofibromatosis types 1, 2 and 3: a study protocol to address a neglected feature
Main Authors: | C. Matthies, E. Rampeltshammer, J. Weiland, M. Breun, R.-I. Ernestus, M. Pham, N. Üceyler |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Brain and Spine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772529421007633 |
Similar Items
-
Neurofibromatosis Type 2 – indications and experiences with Bevacizumab
by: M. Breun, et al.
Published: (2021-01-01) -
Neurofibromatosis Type 2 – phenotypic classification by the Würzburg Severity Score
by: M. Breun, et al.
Published: (2021-01-01) -
Analysis of ADAM9 regulation and function in vestibular schwannoma primary cells
by: Anja Nattmann, et al.
Published: (2020-11-01) -
Neurofibromatosis Type 1 (NF1): Addressing the Transition from Pediatric to Adult Care
by: Radtke HB, et al.
Published: (2023-02-01) -
Neurofibromatosis Type 1 Presenting with Ophthalmic Features: A Case Series
by: Gunjan Jain, et al.
Published: (2016-11-01)